24 May 2013
Keywords: UK, NICE, Novartis, Glivec, Gleevec, GIST
Article | 24 March 2010
The UK’s National Institute for Health and Clinical Excellence (NICE) has given its preliminary view that it is “minded ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
24 March 2010
23 May 2013
© 2013 thepharmaletter.com